Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1991
10/08/1991US5055598 Benzopyran derivatives
10/08/1991US5055490 Stereoisomers of benzonitrile derivatives, useful as cardiac arrhythmiac agents
10/08/1991US5055483 Hypotensive agents, cognition activators, learning enrichment
10/08/1991US5055475 P-hydroxy phenone derivatives and drugs containing these
10/08/1991US5055473 Quinolinyl sulfonamide anti-arrhythmic agents and use thereas
10/08/1991US5055472 Pyrazolopyrimidine type mevalonolactones
10/08/1991US5055470 Method of treatment of ischemia in brain
10/08/1991US5055451 Prevent tissue damage
10/08/1991US5055448 Diuretics
10/08/1991US5055304 Containing disodium adenosine triphosphate and low melting fat or oil-like component; cardiovascular disorders, asthenopia
10/08/1991CA1290347C Diamine derivatives
10/08/1991CA1290334C Substituted 3-(4-phenyl-1-piperazinyl) alkylquinazolin-2, 4-(1h,3h)diones, methods of preparation, compositions and method of use
10/08/1991CA1290331C Prostacyclins and pharmaceuticals containing the same
10/07/1991CA2039684A1 Positive inotropically active 4-quinolyl-dihydropyridines
10/06/1991WO1991015491A1 Heterocyclic compounds as aldose reductase inhibitors
10/06/1991WO1991015482A1 Hmg-co a reductive inhibitors
10/06/1991WO1991015451A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes
10/06/1991CA2079785A1 Derivatives of phenyl-cycloalkanes and cycloalkenes
10/06/1991CA2078888A1 Hmg-coa reductase inhibitors
10/06/1991CA2078210A1 Heterocyclic compounds as aldose reductase inhibitors
10/05/1991CA2039622A1 Substituted azoles, processes for the preparation thereof, agents containing these, and the use thereof
10/04/1991CA2037877A1 6-alpha hydroxy derivatives of mevinic acids
10/03/1991WO1991014668A1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
10/03/1991WO1991014446A1 Crf analogs
10/03/1991CA2039466A1 Cyclophanes, pharmaceutical compositions containing these compounds and processes for preparing them
10/03/1991CA2039458A1 Methods for treating interleukin-1 mediated diseases
10/03/1991CA2039009A1 Isochromane derivatives
10/03/1991CA2037876A1 Substituted cyanoimino benzopyranes
10/02/1991EP0449728A1 4H-pyrrolo (1,2-a)thieno(2,3-f)(1,4)diazepine derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/1991EP0449699A2 Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them
10/02/1991EP0449523A1 Mercapto- or acylthio-trifluoromethyl amide derivatives and their use
10/02/1991EP0449463A2 Method and composition for iontophoresis
10/02/1991EP0449405A2 Use of bisphosphonic acids for the treatment of calcium metabolism disorders
10/02/1991EP0449301A1 Propanobicyclic amine derivatives for CNS disorders
10/02/1991EP0449195A2 Aminobenzene compounds, their production and use
10/02/1991EP0449175A2 Selective adenosine receptor agents
10/02/1991EP0448934A2 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
10/02/1991EP0448765A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity
10/02/1991DE4010355A1 Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use
10/02/1991DE4010097A1 Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung Unsaturated n-benzoxodiazolopyranyllactame, their preparation and use
10/02/1991CN1054978A Novel ascorbic acid derivatives
10/01/1991WO1991015209A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines
10/01/1991US5053519 Hypotensive agents; diuretics; vasodilation
10/01/1991US5053514 Side effect reduction; carbostyril derivatives
10/01/1991US5053427 Guanidino-substituted benzopyrans and their use as pharmaceuticals
10/01/1991US5053424 2-(n-acyl)amino-6,7-dimethoxy tetralines, and pharmaceutical compositions having antihypertensive activity containing same
10/01/1991US5053415 Pyridine derivatives
10/01/1991US5053408 Hexitol derivatives having vasodilative activity
10/01/1991US5053402 Certain glyceryl phosphate-cyclic ammonium compounds useful for treating hypertension
10/01/1991CA2079344A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines
10/01/1991CA2039319A1 Benzoxazine derivatives, process for their preparation and their use for the treatment of for the prophylaxis of diseases
10/01/1991CA2037433A1 Use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity
10/01/1991CA1290097C Peptide enzyme inhibitors
10/01/1991CA1289948C 12- and 13-substituted ergoline derivatives
10/01/1991CA1289887C Composition containing gamma-linolenic acid and calcium
09/1991
09/30/1991WO1991014690A1 Unsaturated n-benzoxodiazopyranyl lactams, their production and use
09/30/1991CA2078139A1 Unsaturated n-benzoxadiazolopyranyllactams, the preparation and use thereof
09/30/1991CA2039398A1 Propanobicyclic amine derivatives for cns disorders
09/29/1991WO1991014681A1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
09/29/1991WO1991014680A1 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same
09/29/1991WO1991014675A1 Bicyclo[3.3.)]octane derivatives, process for producing them and their pharmaceutical use
09/29/1991CA2058922A1 Bicyclo{3.3.0}octane derivatives, process for their production and their pharmaceutical use
09/29/1991CA2038716A1 Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method thereof and drug stabilized thereby
09/28/1991WO1991014674A2 5-lipoxygenase inhibitors
09/28/1991CA2078126A1 5-lipoxygenase inhibitors
09/28/1991CA2039114A1 4h-pyrrolo[1,2-a]thieno[2,3-f]diazepine[1,4]derivatives, a process for their preparation and pharmaceutical compositions holding same
09/27/1991CA2038962A1 Aminobenzene compounds, their production and use
09/25/1991EP0448523A2 Pharmaceutical compositions active on the cardiovascular system, containing 3-methylthiopropionyl L-carnitine
09/25/1991EP0448300A2 Method and composition for coiontophoresis
09/25/1991EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis
09/25/1991EP0448261A2 Tenidap as an inhibitor of the release of elastase by neutrophils
09/25/1991EP0447962A1 Labdanes and process for their preparation
09/25/1991EP0447938A1 Process for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds
09/25/1991EP0447857A1 A polycyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
09/25/1991EP0229823B1 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
09/25/1991CN1054766A Urea derivatives and salts thereof, pharmaceutical compositions containing same, and methods for producing same
09/24/1991US5051534 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
09/24/1991US5051446 Cardiovascular disorders
09/24/1991US5051445 3-amino-propyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
09/24/1991US5051433 For treatment of cardiovascular disorders such as hypertension
09/24/1991US5051432 Heterocyclic 1,4 dihydropyridine derivatives
09/24/1991US5051431 For treatment of congestive heart failure
09/24/1991US5051423 Cardiovascular disorders such as arrhythmia
09/24/1991US5051422 2-substituted-1(4)-aryl piperazines and the process for their preparation
09/24/1991US5051417 Indolythiadiazines for treating heart failure
09/24/1991US5051404 Tripeptide compounds having hypotensive activity
09/24/1991US5051403 Method of treating ischemia-related neuronal damage
09/24/1991US5051263 Controlled-release formulations
09/24/1991US5051132 Cardiovascular disorders for heart failure
09/24/1991CA1289563C Antiarrhythmic imidazoliums, intermediates thereto and method of use
09/24/1991CA1289557C Oxime-ethers of 2,6-dioxobicyclo-[3.3.0] octanones for treatment of heart and circulation diseases
09/21/1991WO1991014679A1 Heterocyclic n-substituted derivatives, their preparation and thepharmaceutical compositions containing them
09/20/1991WO1991014428A1 USE OF 5-TRANS PROSTAGLANDIN F2α AS AN OCULAR HYPOTENSIVE AGENT
09/20/1991CA2076023A1 Use of 5-trans prostaglandin f as an ocular hypotensive agent
09/20/1991CA2038527A1 Therapeutic agent for ischemic diseases
09/20/1991CA2038428A1 Pyrazole derivatives which are angiotensin ii receptor antagonists; their methods of preparation and pharmaceutical compositions in which they are present
09/19/1991WO1991013865A1 Antiarrhythmic agents
09/19/1991WO1991013615A1 New use of bambuterol
09/19/1991WO1991004058A3 Treatment of conditions and disease
09/18/1991EP0447325A1 Novel ascorbic acid derivatives
1 ... 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 ... 1595